Overview

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Status:
Completed
Trial end date:
2005-12-13
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shire
Criteria
Inclusion Criteria:

- Patients with ESRD who currently require treatment for hyperphosphatemia

Exclusion Criteria:

- Female patient who is pregnant or lactating

- Patient has used any investigational product within 30 days of screening